KP-001 is given orally once after breakfast

2 trials

Sponsors

Hideki Kawabata

Conditions

Vascular malformation including VM, LM, and KTSVenous malformation, Lymphatic malformation, Klippel-Trenaunay Syndrome

Phase 3

Phase III confirmatory study of in patients with venous malformation, lymphatic malformation and Klippel-Trenaunay Syndrome

Active, not recruitingJPRN-jRCT2041230064

Hideki KawabataVenous malformation, Lymphatic malformation, Klippel-Trenaunay Syndrome

Start: 2023-08-03Target: 32Updated: 2026-06-29

A Long-term Study of KP-001 in patients with vascular malformation including venous malformation, lymphatic malformation, and Klippel-Trenaunay Syndrome (Phase III)

Active, not recruitingJPRN-jRCT2041230065

Hideki KawabataVascular malformation including VM, LM, and KTS

Start: 2023-08-03Target: 50Updated: 2026-06-29